Form 4: Dayforce Inc. President and COO Stephen Holdridge Sells 1,000 Shares
SEC Form 4
Stephen Holdridge, President and COO of Dayforce Inc., sold 1,000 shares of common stock at $77 per share on November 5, 2024, according to a Form 4 filing with the SEC.
Summary
- On November 5, 2024, Stephen H. Holdridge, the President and COO of Dayforce Inc. (DAY), sold 1,000 shares of the company's common stock at a price of $77 per share.
- The transaction was executed under a Rule 10b5-1 trading plan adopted on May 7, 2024.
- Following the transaction, Holdridge directly owns 122,022 shares of Dayforce Inc., which includes common stock and shares issuable pursuant to restricted stock units (RSUs).
- Holdridge also holds options to buy 65,547 shares of common stock at an exercise price of $70.73, which are fully vested and exercisable.
- Additionally, Holdridge holds various performance units (PSUs) that represent a contingent right to receive shares of common stock based on the achievement of certain performance metrics, with potential vesting dates ranging from February 2025 to March 2027.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider stock sale. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The document outlines future vesting schedules for RSUs and PSUs, contingent on continued employment and achievement of performance metrics.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common among publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency in insider trading activities.
- The use of Rule 10b5-1 trading plans is a common strategy for executives to diversify their holdings while avoiding accusations of trading on inside information.
- Companies like Workday, Oracle, and SAP also have executives who regularly file Form 4s related to stock options, grants, and sales.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by some investors, although the use of a 10b5-1 plan mitigates this concern.
- The vesting of RSUs and PSUs impacts the total number of shares outstanding and could potentially dilute existing shareholders.
Key Dates
| Date | Description |
|---|---|
| May 7, 2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person |
| November 1, 2024 | Date of RSU grant, of which 8,861 shares vest on November 1, 2025, and 8,862 shares vest on each of November 1, 2026 and November 1, 2027 |
| November 5, 2024 | Date of the transaction (sale of 1,000 shares) |
| November 7, 2024 | Date of the Form 4 filing |
| February 24, 2025 | Vesting date of 7,059 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| February 24, 2025 | Vesting of 5,880 PSUs |
| February 28, 2025 | Vesting date of 9,141 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2025 | Vesting date of 12,210 shares of Common Stock issuable pursuant to RSUs |
| November 1, 2025 | Vesting date of 8,861 shares of Common Stock issuable pursuant to RSUs |
| February 28, 2026 | Vesting date of 9,141 shares of Common Stock issuable pursuant to RSUs |
| February 28, 2026 | PSUs will only vest if the achievement of the performance metric under the PSU Agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company |
| March 1, 2026 | Vesting date of 12,210 shares of Common Stock issuable pursuant to RSUs |
| November 1, 2026 | Vesting date of 8,862 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2027 | Vesting date of 12,210 shares of Common Stock issuable pursuant to RSUs |
| March 1, 2027 | PSUs will only vest if the achievement of the performance metric under the PSU Agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company |
| February 28, 2030 | Expiration date of options (right to buy) |
| February 24, 2032 | Expiration date of Performance Units |
| February 28, 2033 | Expiration date of Performance Units |
| March 1, 2034 | Expiration date of Performance Units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.